
Quoin Pharmaceuticals Investor Relations Material
Latest events

Q4 2023
Quoin Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Quoin Pharmaceuticals Ltd
Access all reports
Quoin Pharmaceuticals Ltd is a U.S.-based specialty pharmaceutical company focused on the development and commercialization of therapeutic products for rare and orphan diseases. The company’s lead programs target conditions such as Netherton syndrome and other rare skin disorders. Quoin develops its drug candidates using proprietary delivery technologies and aims to address high unmet medical needs through both clinical research and strategic partnerships. The company is headquartered in Ashburn, Virginia, and its shares are listed on the NASDAQ.
Key slides for Quoin Pharmaceuticals Ltd


Corporate Presentation
Quoin Pharmaceuticals Ltd


Corporate Presentation
Quoin Pharmaceuticals Ltd
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
QNRX
Country
🇺🇸 United States